A lot of big pharma companies use our tech already. We're just putting it into wearables and IOT devices now. This means lower prices for devices but the technology will be available and accessible at a mass scale.
In my mind, Mobvoi deal is just a nice POC for our wearable tech.
Conneqt will be the brand that is competing with and out performing the big tech companies like Apple.
In the next few years we don't exactly need a big name to use our tech like BRN has with Mercedes.
We are aiming to disrupt and beat out the big names. We can do this because of the decades of validation our tech has been through.
We already have the gold standard tech in BP diagnostics..
The market in aus doesn't really appreciate any of the above.. I think in the US they may be less sceptical and see that CDX is a true gem imo. By the time we are listed in the US we should be seeing sales of the Mobvoi watch with our tech in it, which will work well as a POC for the US investors.
Add to My Watchlist
What is My Watchlist?
